Is There Evidence that Topical Formulations Can Support the Microbiome?

Media formats available:

Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming
Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming
Atopic Dermatitis
Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming
- Brad Glick, DO, MPH
- Amit Sharma, MD
- Krystina Khalil, DO
New AD Guidelines: A Paradigm Shift in AD Care
New AD Guidelines: A Paradigm Shift in AD Care
Atopic Dermatitis
New AD Guidelines: A Paradigm Shift in AD Care
- Peter Lio, MD
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
DermWire TV
DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
Other Dermatitis
FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
- Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer

PracticalDermatology